22.626 articles found

Evaluation of the effects of deep brain stimulation of the subthalamic nucleus and levodopa treatment on parkinsonian voice using perturbation, nonlinear dynamic, and perceptual analysis.

Zhou XP, Lee VS, Wang EQ, Jiang JJ.

Folia Phoniatr Logop · 2009-07-09

DOI: 10.1159/000227996PMID: 19590218

THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN

SUN QUN, TAFESSE LAYKEA, VICTORY SAM.

· 2009-07-08

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Mony L, Kew JN, Gunthorpe MJ, Paoletti P.

Br J Pharmacol · 2009-07-08

DOI: 10.1111/j.1476-5381.2009.00304.xPMID: 19594762

MONOGLYCERIDE OF ACETOACETATE AND DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

HENDERSON SAMUEL T.

· 2009-07-02

Monoglyceride of Acetoacetate and Derivatives for the Treatment of Neurological Disorders

HENDERSON SAMUEL T.

· 2009-07-02

Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.

Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.

Neuropharmacology · 2009-07-02

DOI: 10.1016/j.neuropharm.2009.06.030PMID: 19576910

LIGHT-EMITTING DEVICE AND METHOD FOR PROVIDING PHOTOTHERAPY TO THE BRAIN

DE TABOADA LUIS, STREETER JACKSON.

· 2009-07-01

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

Eskow KL, Dupre KB, Barnum CJ, Dickinson SO, Park JY, Bishop C.

Synapse · 2009-07-01

DOI: 10.1002/syn.20630PMID: 19309758

Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats.

Steece-Collier K, Soderstrom KE, Collier TJ, Sortwell CE, Maries-Lad E.

J Comp Neurol · 2009-07-01

DOI: 10.1002/cne.22037PMID: 19399877

Development of vaccination approaches for the treatment of neurological diseases.

Federoff HJ.

J Comp Neurol · 2009-07-01

DOI: 10.1002/cne.22034PMID: 19399901

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A.

Mov Disord · 2009-07-01

DOI: 10.1002/mds.22586PMID: 19412944

Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.

Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.

Mov Disord · 2009-07-01

DOI: 10.1002/mds.22596PMID: 19425079